Advertisement

Human Immunodeficiency Virus Type 1 Accessory Genes

Targets for Therapy
  • Sagar Kudchodkar
  • T. Nagashunmugam
  • Velpandi Ayyavoo
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Keywords

Human Immunodeficiency Virus Acquire Immune Deficiency Syndrome Simian Immunodeficiency Virus Accessory Gene Human Immunodefi 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Levy, J. A., 1994, HIV and the Pathogenesis of AIDS, ASM Press, Washington, D.C., pp. 35–52.Google Scholar
  2. 2.
    Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A., 1996, HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science 272:872–877.PubMedCrossRefGoogle Scholar
  3. 3.
    Lu, Z., Berson, J. F., Chen, Y., Turner, J. D., Zhang, T., Sharron, M., Jenks, M. H., Wang, Z., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C., and Doms, R. W., 1997, Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains, Proc. Natl. Acad. Sci. USA 946:426–6431.Google Scholar
  4. 4.
    Preston, B. D., 1997, Technical comments: Reverse transcriptase fidelity and HIV-1 variation, Science 275:228–229.PubMedCrossRefGoogle Scholar
  5. 5.
    Prasad, V. R., Drosopoulos, W. C., and Wainberg, M. A., 1997, Technical comments: Reverse transcriptase fidelity and HIV-1 variation, Science 275:230–231.Google Scholar
  6. 6.
    Adachi, A., Ono, N., Sakai, H., Ogawa, K., Shibata, R., Kiyomasu, M., Masuike, H., and Ueda, S., 1991, Generation and characterization of the human immunodeficiency virus type 1 mutants, Arch. Virol. 117:45–58.CrossRefPubMedGoogle Scholar
  7. 7.
    Akari, H., Sakuragi, J., Takebe, Y., Tomonaga, K., Kawamura, M., Fukasawa, M., Miura, T., Shinjo, T., and Hayami, M., 1992, Biological characterization of the human immunodeficiency virus type 1 and type 2mutants in human peripheral blood mononuclear cells, Arch. Virol. 123:157–167.CrossRefPubMedGoogle Scholar
  8. 8.
    Cheynier, R., Langlade-Demoyen, P., Marescot, M.-R., Blanche, S., Blondin, G., Wain-Hobson, s., Griscelli, C., Vilmer, E., and Plata, F., 1992, Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers, Eur.J. Immunol. 22:2211–2217.PubMedCrossRefGoogle Scholar
  9. 9.
    Rowland-Jones, S., Nixon, D. F., Aldhous, M. C., Gotch, F., Ariyoshi, K., Hallam, N., Kroll, J. S., Froebel, K., and McMichael, A., 1993, HIV-specific cytotoxic T-cellactivityin an HIV-exposed but uninfected infant, Lancet 341:860–861.PubMedCrossRefGoogle Scholar
  10. 10.
    Aldhous, M. C., Watret, K. C., Mok, J. Y. Q., Bird, A. G., and Froebel, K. S., 1994, Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection, Clin. Exp. Immunol. 97:61–67.PubMedGoogle Scholar
  11. 11.
    Miller, R. H., and Sarver, N., 1997, HIV accessory proteins as therapeutic targets, Nature Med. 3:389–394.PubMedCrossRefGoogle Scholar
  12. 12.
    Wang, B., Ugen, K. E., Srikantan, V., Agadjanyan, M. G., Dang, K., Rafaeli, Y., Sato, A. I., Boyer, J., Williams, W. V., and Weiner, D., 1993, Gene inoculation generates immune responses against human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. USA 90:4156–4160.PubMedCrossRefGoogle Scholar
  13. 13.
    Chattergoon, M., Boyer, J., and Weiner, D. B., 1997, Genetic immunization: A new era in vaccines and immune therapeutics, FASEBJ. 11:753–763.Google Scholar
  14. 14.
    Ayyavoo, V., Nagashunmugam, T., Boyer, J., Mahalingam, S., Fernandes, L. S., Le, P., Lin, J., Nguyen, C., Chattergoon, M., Goedert, J. J., Friedman, H., and Weiner, D. B., 1997, Development of genetic vaccine for pathogenic genes: Construction of attenuated vif DNA immunization cassettes, AlDS 11:1433–1444.Google Scholar
  15. 15.
    Arya, S. K., and Gallo, R. C., 1986, Three novel genes of human T-lymphotropic virus type III: Immune reactivity of their products with sera from acquired immune deficiency syndrome patients, Proc. Natl. Acad. Sci. USA 83:2209–2213.PubMedCrossRefGoogle Scholar
  16. 16.
    Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R. C., and Wong-Staal, F., 1987, The sorgene of HIV-1 is required for efficient virus transmission in vitro, Science 237:888–893.PubMedCrossRefGoogle Scholar
  17. 17.
    Garrett, E. D., Tiley, L., and Cullen, B., 1991, rev activates expression of the human immunodeficiency virus type 1 vifand vpr gene products, J. Virol. 65:1653–1657.PubMedGoogle Scholar
  18. 18.
    Schwartz, S., Felber, B., and Pavlakis, G., 1991, Expressions of human immunodeficiency virus type 1 vif and vpr mRNAs is rev-dependent and regulated by splicing, Virology 183:677–686.CrossRefPubMedGoogle Scholar
  19. 19.
    Cullen, B. R., and Greene, W. C., 1989, Regulatory pathways governing HIV-1 replication, Cell 58:423–426.CrossRefPubMedGoogle Scholar
  20. 20.
    Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., and Martin, M. A., 1987, The HIV “A” (sor) gene product is essential for virus infectivity, Nature 328:728–730.CrossRefPubMedGoogle Scholar
  21. 21.
    Aldrovandi, G. M., and Zack, J. A., 1996, Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice, J. Virol. 70:1505–1511.PubMedGoogle Scholar
  22. 22.
    Oberste, M. S., and Gonda, M. A., 1992, Conservation of amino-acid sequence motifs in lentivirus vif proteins, Virus Genes 6:95–102.CrossRefPubMedGoogle Scholar
  23. 23.
    Sakai, H., Shibata, R., Sakuragi, J.-I., Sakuragi, S., Kawamura, M., and Adachi, A., 1993, Celldependent requirement of human immunodeficiency virus type 1 vif protein for maturation of virus particles, J. Virol. 67:1663–1666.PubMedGoogle Scholar
  24. 24.
    Ma, X.-Y., Sova, P., Chao, W., and volsky, D. J., 1994, Cysteine residues in the vif protein of human immunodeficiency virus type 1 are essential for viral infectivity, J. Virol. 68:1714–1720.PubMedGoogle Scholar
  25. 25.
    Sova, P., Chao, W., and Volsky, D. J., 1997, The redox state of cysteines in human immunodeficiency virus type 1 vif in infected cells and in virions, Biochem. Biophys. Res. Commun. 240:257–260.CrossRefPubMedGoogle Scholar
  26. 26.
    Goncalves, J., Jallepalli, P., and Gabuzda, D. H., 1994, Subcellular localization of the Vif protein human immunodeficiency virus type 1, J. Virol. 68:704–712.PubMedGoogle Scholar
  27. 27.
    Karczewski, M. R, and Strebel, K., 1996, Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein, J. Virol. 70:494–507.PubMedGoogle Scholar
  28. 28.
    Hoglund, S., Ohaen, A., Lawrence, K., and Gabuzda, D., 1994, Role of vif during packing of the core of HIV-1, Virology 201:349–355.PubMedCrossRefGoogle Scholar
  29. 29.
    Simon, J, H., Fouchier, R. A., Southerling, T. E., Guerra, C. B., Grant, C. K., and Malim, M. H., 1997, The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells, J. Virol. 71:5259–5267.PubMedGoogle Scholar
  30. 30.
    Bouyac, M., Courcoul, M., Bertoia, G., Baudat, Y., Gabuzda, D., Blanc, D., Chazal, N., Boulanger, P., Sire, J., Vigne, R., and Spire, B., 1997, Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor, J. Virol. 71:9358–9365.PubMedGoogle Scholar
  31. 31.
    Göttlinger, H. G., Sodroski, J. G., and Haseltine, W. A., 1989, Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1, Proc. Natl. Sci. Acad. USA 86:5781–5785.CrossRefGoogle Scholar
  32. 32.
    Wang, C.-T., and Barklis, E., 1993, Assembly, processing and infectivity of human immuno-deficiency virus type 1 Gag mutants, J. Virol. 67:4264–4273.PubMedGoogle Scholar
  33. 33.
    Borman, A. M., Quillent, C., Charneau, P., Dauguet, C., and Clavel, F., 1995, Human immunodeficiency virus type 1 Vif mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity, J. Virol. 69:2058–2067.PubMedGoogle Scholar
  34. 34.
    Courcoul, M., Patience, C., Rey, F., Blanc, D., Harmache, A., Sire, J., Vigne, R., and Spire, B., 1995, Peripheral blood mononuclear cells produce normal amounts of defective Vif human immunodeficiency virus type 1 particle which are restricted for the preretrotran-scription steps, J. Virol. 69:2068–2074.PubMedGoogle Scholar
  35. 35.
    Simon, J. H., and Malim, M. H., 1996, The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes, J. Virol. 70:5297–5305.PubMedGoogle Scholar
  36. 36.
    Fouchier, R. A., Simon, J. H., Jaffe, A. B., and Malim, M. H., 1996, Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins, J. Virol. 70:8263–8269.PubMedGoogle Scholar
  37. 37.
    Fan, L., and Peden, K., 1992, Cell-free transmission of Vif mutants of HIV-1, Virology 190:19–29.CrossRefPubMedGoogle Scholar
  38. 38.
    Von Schwedler, U., Song, J., Aiken, C., and Trono, D., 1993, Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells, J. Virol. 67:4945–4955.Google Scholar
  39. 39.
    Trono, D., 1995, HIV accessory proteins: Leading roles for the supporting cast, Cell 82:189–192.CrossRefPubMedGoogle Scholar
  40. 40.
    Wieland, U., Hartmann, J., Suhr, H., Salzberger, B., Eggers, H. J., and Kuhn, J. E., 1994, In vivo genetic variability of the HIV-1 vif gene, Virology 203:43–51.CrossRefPubMedGoogle Scholar
  41. 41.
    Sova, P., van Ranst, M., Gupta, P., Balachandran, R., Chao, W., Itescu, S., McKinley, G., and Volsky, D. J., 1995, The conservation of intact human immunodeficiency virus type 1 (HIV-1) vif gene in primary virus isolates from symptomatic and asymptomatic individuals and in vivo, J. Virol. 69:2557–2564.PubMedGoogle Scholar
  42. 42.
    Zhang, L., Huang, Y., Yuan, H., Tuttleton, S., and Ho, D. D., 1997, Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection, Virology 228 340–349.CrossRefPubMedGoogle Scholar
  43. 43.
    Kan, N. C., Franchini, G., Wong-Staal, F., DuBois, G. C., Robey, G., Lautenberger, J. A., and Papas, T. S., 1986, Identification of HTLV-II/LAVsor gene product and detection of antibodies in human sera, Science 231:1553–1555.PubMedCrossRefGoogle Scholar
  44. 44.
    Schwander, S., Braun, R. W., Kuhn, J. E., Hufert, F. T., Kern, P., Dietrich, M., and Wieland, U., 1992, Prevalence of antibodies to recombinant virion infectivity factor in the sera of prospectively studied patients with HIV-1 infection, J. Med. Virol. 36:142–146.PubMedCrossRefGoogle Scholar
  45. 45.
    O’Neil, C., Lee, D., Clewley, G., Johnson, M. A., and Emery, V. C., 1997, Prevalence of antivif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed Vif protein, J. Med. Virol. 51:139–144.PubMedCrossRefGoogle Scholar
  46. 46.
    Subbramanian, R. A., and Cohen, E. A., 1994, Molecular biology of the human immunodeficiency virus accessory proteins, J. Virol. 68 6831–6835.PubMedGoogle Scholar
  47. 47.
    Schwartz, S., Felber, B. K., Fenyo, E.-M., and Pavlakis, G. N., 1990, Env and vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs, J. Virol. 64:5448–5456.PubMedGoogle Scholar
  48. 48.
    Maldarelli, F., Chen, M.-Y., Willey, R. L., and Strebel, K., 1993, Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane, J. Virol. 67:5056–5061.PubMedGoogle Scholar
  49. 49.
    Strebel, K., Klimkait, T., Maldarelli, E, and Martin, M. A., 1989, Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein, J. Virol. 63:3784–3791.PubMedGoogle Scholar
  50. 50.
    Cohen, E. A., Terwilliger, E. F., Sodroski, J. G., and Haseltine, W. A., 1988, Identification of a protein encoded by the vpu gene of HIV-1, Nature 334:532–534.PubMedCrossRefGoogle Scholar
  51. 51.
    Schubert, U., and Strebel, K., 1994, Differential activities of the human immunodeficiency virusencoded Vpu protein are regulated by phosphorylation and occurs in different compartments, J. Virol. 68:2260–2271.PubMedGoogle Scholar
  52. 52.
    Chen, M.-T., Malderelli, F., Karczewski, M. K., Willey, R. L., and Strebel, K., 1993, Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: The cytoplasmic domain of CD4 contributes to vpu sensitivity, J. Virol. 67:3877–3884.PubMedGoogle Scholar
  53. 53.
    Schubert, U., Henklein, P., Boldyreff, B., Wingender, E., Strebel, K., and Porstmann, T., 1994, The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions ser52 and ser56 within a predicted a-helix-turn-a-helix motif, J. Mol. Biol. 236:16–25.CrossRefPubMedGoogle Scholar
  54. 54.
    Paul, M., and Jabbar, M. A., 1997, Phosphorylation of both phosphoacceptor sites in the HIV-1 vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4, Virology 232:207–216.CrossRefPubMedGoogle Scholar
  55. 55.
    Jabbar, M. A., and Nayak, D. P., 1990, Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane, J. Virol. 64 6297–6304.PubMedGoogle Scholar
  56. 56.
    Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K., 1992, Human immunodeficiency virus type 1 Vpu protein regulates formation of intracellular gp160-CD4 complexes, J. Virol. 66:226–234.PubMedGoogle Scholar
  57. 57.
    Raja, N. U., Vincent, M. J., and Jabbar, M. A., 1993, Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane ER retention signal, J. Gen. Virol. 74:2085–2097.PubMedCrossRefGoogle Scholar
  58. 58.
    Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., and Klausner, R. D., 1988, Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160, Proc. Natl. Acad. Sci. USA 85:9580–9584.PubMedCrossRefGoogle Scholar
  59. 59.
    Kerkau, T., Bacik, I., Bennink, J. R., Yewdell, J. W., Hunig, T., Schimpl, A., and Schubert, U., 1997, The human immunodeficiencyvirus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules, J. Exp. Med. 185:1295–1305.CrossRefPubMedGoogle Scholar
  60. 60.
    Vincent, M. J., Raja, N. U., and Jabbar, M. A., 1993, The human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum, J. Virol. 67:5538–5549.PubMedGoogle Scholar
  61. 61.
    Lenburg, M. E., and Landau, N. R., 1993, Vpu-induced degradation of CD4: Requirement for specific amino acid residues in the cytoplasmic domain of CD4, J. Virol. 67:6542–6550.Google Scholar
  62. 62.
    Schubert, U., Anton, L. C., Bacik, I., Cox, J. H., Bour, S., Bennink, J. R., Orlowski, M., Strebel, K., and Yewdell, J. W., 1998, CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway, J. Virol. 72:2280–2288.PubMedGoogle Scholar
  63. 63.
    Bonifacino, J. S., and Klausner, R. D., 1994, Degradation of proteins in the endoplasmic reticulum, in: Cellulur Proteolytic Systems (A. Ciechanover and A. L. Schwartz, eds.), Vol. 15, Wiley-Liss, New York, pp. 137–160.Google Scholar
  64. 64.
    Klimkait, T., Strebel, R, Hoggan, M. D., Martin, M. A., and Orenstein, J. M., 1990, The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release, J. Virol. 64:621–629.PubMedGoogle Scholar
  65. 65.
    Terwilliger, E. F., Cohen, E. A., Lu, Y., Sodroski, J. G., and Haseltine, W. A., 1989, Functional role of human immunodeficiency virus type 1 vpu, Proc. Natl. Acad. Sci. USA 86:5163–5167.PubMedCrossRefGoogle Scholar
  66. 66.
    Gottlinger, H. G., Dorfman, T., Cohen, E. A., and Haseltine, W. A., 1993, Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses, Proc. Natl. Acad. Sci. USA 90:7381–7385.PubMedCrossRefGoogle Scholar
  67. 67.
    Colombini, S., Arya, S. R, Reitz, M. S., Jagodzinski, L., Beaver, B., and Wong-Staal, F., 1989, Structure of simian immunodeficiency virus regulatory genes, Proc. Natl. Acad. Sci. USA 86:4813–4817.PubMedCrossRefGoogle Scholar
  68. 68.
    Shibata, R., Miura, T., Hayami, M., Ogawa, K., Sakai, H., Kiyomasu, T., Ishimoto, A., and Adachi, A., 1990, Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus (SIV), J. Virol. 64:742–747.PubMedGoogle Scholar
  69. 69.
    Ahmad, N., Maitra, R. R, and Venkatesan, S., 1989, Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication, Proc. Natl. Acad. Sci. USA 86:6111–6115.PubMedCrossRefGoogle Scholar
  70. 70.
    Cheng-Mayer, C., Iannello, P., Shaw, R, Luciw, P. A., and Levy, J. A., 1989, Differential effects of nef on HIV replication: Implications for viral pathogenesis in the host, Science 246:1629–1632.PubMedCrossRefGoogle Scholar
  71. 71.
    Niederman, T. M. J., Thielan, B. J., and Ratner, L., 1989, Human immunodeficiency virus type 1 negative factor is a transcriptional silencer, Proc. Natl. Acad. Sci. USA 86:1128–1132.PubMedCrossRefGoogle Scholar
  72. 72.
    Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C., and Feinberg, M. B., 1994, The human immunodeficiency virus-1 nefgene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages, J. Exp. Med. 179:101–113.CrossRefPubMedGoogle Scholar
  73. 73.
    Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C., 1991, Importance of the nef gene for maintenance of high virus loads and for development of AIDS, Cell 65:651–662.PubMedCrossRefGoogle Scholar
  74. 74.
    Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludford-Menting, M., Hooker, D. J., McPhee, A., Greenway, A. L., Ellett, A., Chatfield, C., et al., 1995, Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science 270:988–991.PubMedCrossRefGoogle Scholar
  75. 75.
    Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C., 1995, Brief report: Absence of intact nef sequences in a long term survivor with nonprogressive HIV-1 infection, N. Engl. J. Med. 332:228–232.CrossRefPubMedGoogle Scholar
  76. 76.
    Switzer, W. M., Wiktor, S., Soriano, V., Silva-Grace, A., Mansinho, R, Coulibaly, I. M., Ekpini, E., Greenberg, A. E., Folks, T. M., and Heneine, W., 1998, Evidence of Nef truncation in human immunodeficiency virus type 2 infection, J. Infect. Dis. 177:65–71.PubMedCrossRefGoogle Scholar
  77. 77.
    Welker, R., Kottler, H., Kalbitzer, H. R., and Kräusslich, H. G., 1996, Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase, Virology 219:228–236.CrossRefPubMedGoogle Scholar
  78. 78.
    Pandori, M. W., Fitch, N. J, Craig, H. M., Richman, D. D., Spina, C. A., and Guatelli, J. C., 1996, Producer cell modification of human immunodeficiency virus type 1: Nef is a virion protein, J. Virol. 70:4283–4290.PubMedGoogle Scholar
  79. 79.
    Bukovsky, A. A., Dorfman, T., Weimann, A., and Gottlinger, H. G., 1997, Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease, J. Virol. 71:1013–1018.PubMedGoogle Scholar
  80. 80.
    Klotman, M. E., Kim, S.Y., Buchbinider, A., DeRossi, A., Baltimore, D., and Wong-Staal, F., 1992, Kinetics of expression of multiply spliced RNA in early human immunodeficiency type 1 infection of lymphocytes and monocytes, Proc. Natl. Acad. Sci. USA 89:1148–1152.PubMedCrossRefGoogle Scholar
  81. 81.
    Ratner, L., Starcich, B., Josephs, S. F., Hahn, B. H., Reddy, E. P., Livak, K. J., Petteway, S. R., Pearson, M. L., Haseltine, W. A., Arya, S. R, and Wong-Staal, F., 1985, Polymorphism of the 3’ open reading frame of the virus associated with the acquired immune deficiency syndrome, human T cell lymphotropic virus type III, Nucleic Acids Res. 13:8219–8229.PubMedCrossRefGoogle Scholar
  82. 82.
    Ratner, L., Fisher, A., Jagodzinski, L. L., Mitsuya, H., Liou, R.-S., Gallo, R. C., and Wong-Staal, F., 1987, Complete nucleotide sequences of functional clones of the AIDS virus, AIDSRes. Hum. Retrovir. 3:57–69.Google Scholar
  83. 83.
    Myers, G., Berzofsky, J. A., Rabson, A. B., Smith, T. F., and Wong-Staal, F., eds., 1990, Human Retroviruses and AIDS, Los Alamos National Laboratory, Los Alamos, New Mexico.Google Scholar
  84. 84.
    Delassus, S., Cheynier, R., and Wain-Hobson, S., 1991, Evolution of human immunodeficiency type 1 nefand long terminal repeat sequences over 4 years in vivo and in vitro, J. Virol. 65:225–231.PubMedGoogle Scholar
  85. 85.
    Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-Moisewisch, F., and Swanstorm, R., 1993, Analysis of human immunodeficiency virus type 1 nef genesequences present in vivo, J. Virol. 67:4639–4650.PubMedGoogle Scholar
  86. 86.
    Culmann, B., Gomard, E., Kieny, M.-P., Guy, B., Dreyfus, F., Saimot, A.-G., Sereni, D., and Levy, J.-P., 1989, An antigenic peptide of the HIV-1 Nef protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules, Eur.J. Immunol. 19:2383–2386.PubMedCrossRefGoogle Scholar
  87. 87.
    Bahraoui, E., Yagello, M., Billaud, J.-N., Sabatier, J.-M., Guy, B., Muchmore, E., Girard, M., and Gluckman, J. C., 1990, Immunogenicity of the human immunodeficiencyvirus (HIV) recombinant nef gene product: Mapping of T-cell and B-cell epitopes in immunized chimpanzees, AIDSRes. Hum. Retrovir. 6:1087–1098.CrossRefGoogle Scholar
  88. 88.
    Koenig, S., Fuerst, T. R., Wood, L. V., Woods, R. M., Suzich, J. A., Jones, G. M., de la Cruz, V. F., Davey, R T., Venkatesan, S., Moss, B., Biddison, W. E., and Fauci, A. S., 1990, Mapping the fine specificity of a cytolytic T cell response to HIV-1, J. Immunol. 145:127–135.PubMedGoogle Scholar
  89. 89.
    Zweig, M., Samuel, K. P., Showalter, S. D., Bladen, S. V., DuBois, G. C., Lautenberger, J. A., Hodge, D. R., and Papas, T. S., 1990, Heterogeneity of Nef proteins in cells infected with human immunodeficiency virus type 1, Virology 179:504–507.CrossRefPubMedGoogle Scholar
  90. 90.
    Kaminchik, J., Bashan, N., Itach, A., Sarver,, Gorecki, M., and Panel, A., 1991, Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells, J. Virol. 65:583–588.PubMedGoogle Scholar
  91. 91.
    Bachelerie, F., Alcami, J., Hazan, U., Israel, B., Goud, F., Arenzana-Seisdedos, F., and Virelizier, J.-I., 1990, Constitutive expression of human immunodeficiency virus (HIV) Nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity, J. Virol. 64:3059–3062.PubMedGoogle Scholar
  92. 92.
    Fackler, O. T., Kienzle, N., Kremmer, E., Boese, A., Schramm, B., Klimkait, T., Kucherer, C., and Mueller-Lantzsch, N., 1997, Association of human immunodeficiency virus Nef protein with actin is myristylation dependent and influences in subcellular localization, Eur.J. Biochem. 247:843–851.CrossRefPubMedGoogle Scholar
  93. 93.
    Kohleisen, B., Neumann, M., Herrmann, R., Brack-Werner, R., Krohn, K.,, J., Ovod, V., Ranki, A., and Erfle, V., 1992, Cellular localization of Nef expressed in persistently HIV-1 infected low-producer astrocytes, AIDS 6:1427–1436.PubMedCrossRefGoogle Scholar
  94. 94.
    Murti, K. G., Brown, P. S., Ratner, L., and Garcia, J. V., 1993, Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line, Proc. Natl. Acad. Sci. USA 90:11895–11899.PubMedCrossRefGoogle Scholar
  95. 95.
    Franken, P., Arold, S., Padilla, A., Bodeus, M., Hoh, F., Strub, M. P., Boyer, M., Jullien, M., Benarous, R., and Dumas, C., 1997, HIV-1 Nef protein: Purification, crystallizations, and preliminary X-ray diffraction studies, Protein Sci. 6:2681–2683.PubMedCrossRefGoogle Scholar
  96. 96.
    Backer, J. M., Mendola, C. E., Fairhurst, J. L., and Kovedsi, I., 1991, The HIV-1 nefprotein does not have guanine nucleotide binding, GTPase, or autophosphorylation activities, AIDSRes. Hum. Retrovir. 7:1015–1020.Google Scholar
  97. 97.
    Harris, M., and Coates, K., 1993, Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: A role for myristoylation, J. Gen. Virol. 74:1581–1589.PubMedCrossRefGoogle Scholar
  98. 98.
    Luo, T., Livingston, R. A., and Garcia, J. V., 1997, Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with cellular serine/threonine kinase, J. Virol. 71:9524–9530.PubMedGoogle Scholar
  99. 99.
    Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C., 1994, Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes, Proc. Natl. Acad Sci. USA 91:1539–1543.PubMedCrossRefGoogle Scholar
  100. 100.
    Nunn, M. F., and Marsh, J. W., 1996, Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family, J. Virol. 70:6157–6161.PubMedGoogle Scholar
  101. 101.
    Lu, X., Wu, X., Plemenitas, A., Yu, H., Sawai, E. T., Abo, A., and Peterlin, B. M., 1996, CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1, Curr. Biol. 6:1677–1684.CrossRefPubMedGoogle Scholar
  102. 102.
    Saksela, K., Cheng, G., and Baltimore, D., 1995, Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down regulation of CD4, EMBO J. 14:484–491.PubMedGoogle Scholar
  103. 103.
    Arold, S., Franken, P., Strub, M. P., Hoh, F., Benichou, S., Benarous, R., and Dumas, C., 1997, The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling, Structure 5:1361–1372.CrossRefPubMedGoogle Scholar
  104. 104.
    Rossi, F., Evstafieva, A., Pedrali-Noy, G., Gallina, A., and Milanesi, G., 1997, HsN3 proteasomal subunit as a target for human immunodeficiency virus type 1 Nef protein, Virology 237:33–45.CrossRefPubMedGoogle Scholar
  105. 105.
    Garcia, J. V., and Miller, A. D., 1991, Serine phosphorylation-independent downregulation of cell surface CD4 by nef, Nature 350:508–511.CrossRefPubMedGoogle Scholar
  106. 106.
    Anderson, S., Shugars, D. C., Swanstrom, R., and Garcia, J. V., 1993, Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells, J. Virol. 67:4923–4931.PubMedGoogle Scholar
  107. 107.
    Mariani, R., and Skowronski, J., 1993, CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type-1 infected individuals, Proc. Natl. Acad. Sci. USA 90: 5549–5553.PubMedCrossRefGoogle Scholar
  108. 108.
    Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D., 1994, Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain, Cell 76853–864.Google Scholar
  109. 109.
    Laurent, A. G., Hovanessian, A. G., Riviere, Y., Krust, B., Regnault, A., Montagnier, L., Findeli, A., Kieny, M. P., and Guy, B., 1990, Production of a non-functional nef protein in human immunodeficiency virus type 1 infected CEM cells, J. Gen. Virol. 71:2273–2281.PubMedCrossRefGoogle Scholar
  110. 110.
    Greenway, A. L., McPhee, D. A., Grgacic, E., Hewish, D., Lucantoni, A., Macreadie, I., and Azad, A., 1994, Nef 27, but not the Nef 25 isoform of human immunodeficiency virus type 1 pNL43 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cell, Virology 198:245–256.CrossRefPubMedGoogle Scholar
  111. 111.
    Bandres, J. C., Shaw, A. S., and Ratner, L., 1995, HIV-1 nef protein downregulation of CD4 surface expression: Relevance of Ick binding, Virology 207:338–341.CrossRefPubMedGoogle Scholar
  112. 112.
    Rhee, S. S., and Marsh, J. W., 1994, HIV-1 nef activity in murine T cells: CD4 modulation and positive enhancement, J. Immunol. 152:5128–5134.PubMedGoogle Scholar
  113. 113.
    Foti, M., Mangasarian, A., Pipet, V., Lew, D. P., Krause, K. H., Trono, D., and Carpentier, J. L., 1997, Nef-mediated clathrin-coated pit formation, J. Cell Biol. 139:37–47.CrossRefPubMedGoogle Scholar
  114. 114.
    Greenberg, M. E., Bronson, S., Lock, M., Neumann, M., Pavlakis, G. N., and Skowronski, J., 1997, Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation, EMBO 16:6964–6976.CrossRefGoogle Scholar
  115. 115.
    Schwartz, O., Marechal, V., Danos, O., and Heard, J. M., 1995, Human immunodeficiency virus type-1 Nef increases the efficiency of reverse transcription in the infected cell, J Virol. 69:4053–4059.PubMedGoogle Scholar
  116. 116.
    Luna, S., Chambers, I., and Berg, P., 1991, Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA, Proc. Natl. Acad. Sci. USA 88:5326–5330.CrossRefGoogle Scholar
  117. 117.
    Niederman, T. M. J., Garcia, J. V., Hastings, W. R., Luna, S., and Ratner, L., 1992, Human immunodeficiency virus type 1 Nef protein inhibits NF-kB induction in human T cells, J. Virol. 66:6213–6219.PubMedGoogle Scholar
  118. 118.
    Skowronski, J,, Parks, D., and Mariani, R., 1993, Altered T-cell activation and development in transgenic mice expressing the HIV-1 nef gene, EMBO J. 12:703–713.PubMedGoogle Scholar
  119. 119.
    Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., and Baltimore, D., 1998, HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes, Nature 191:397–401.Google Scholar
  120. 120.
    Culman, B., Gomard, E., Kieny, M.-P., Guy, B., Dreyfus, F., Saimont, A.-G., Sereni, D., Sicard, D., and Levy, J. P., 1991, Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 Nef protein, J. Immunol. 146:1560–1565.Google Scholar
  121. 121.
    Sabatier, J. M., Clerget-Raslain, B., Fontan, G., Fenouillet, E., Rochat, H., Granier, C., Gluckman, J. C., Van Rietschoten, J., Montagnier, L., and Bahraoui, E., 1989, Use of synthetic peptides for the detection of antibodies against the nef regulation protein in sera of HIV-infected patients, AIDS 3:215–220.PubMedCrossRefGoogle Scholar
  122. 122.
    Bahraoui, E., Benjouad, A., Sabatier, J. M., Allain, J. P., Laurian, Y., Montagnier, L., and Gluckman, J.-C., 1990, Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection, Blood 76:257–264.PubMedGoogle Scholar
  123. 123.
    Kienzle, N., Broke, M., Harthus, H.-P., Enders, M., Erfle, V., Buck, M., and Muller-Lantzsch, N., 1991, Immunological study of the nef protein from HIV-1 polyclonal and monoclonal antibodies, Arch. Virol. 124:123–132.CrossRefGoogle Scholar
  124. 124.
    Reiss, P., deRonde, A., Lange, J., deWolf, F., Dekker, J., Debouck, C., and Goudsmit, J., 1989, Antibody response to the viral negative factor (nef) in HIV-1 infection: A correlate of levels of HIV-1 expression, AIDS 3:227–235.PubMedCrossRefGoogle Scholar
  125. 125.
    Winter, N., Lagranderie, M., Rauzier, J., Timm, J., Leclerc, C., Guy, B., Kieny, M. P., Gheorghiu, M., and Gicquel, B., 1991, Expression of heterologous genes in Mycobacterium bovis BCG Induction of a cellular response against HIV-1 Nef protein, Gene 109:47–54.CrossRefPubMedGoogle Scholar
  126. 126.
    Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., and Desrosiers, R. C., 1992, Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene, Science 258:1938–1941.PubMedCrossRefGoogle Scholar
  127. 127.
    Wong-Staal, F., Chanda, P. K., and Gbrayeb, J., 1987, Human immunodeficiencyvirus type 1: The eighth gene, AIDS Res. Hum. Retrovir. 3:33–39.PubMedGoogle Scholar
  128. 128.
    Myers, G., Korber, B., Barzofsky, J. A., Smith, R. F., and Pavlakis, G. N., 1992, Human Retroviruses and AIDS, Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, New Mexico.Google Scholar
  129. 129.
    Arrigo, S. J., and Chen, I. S. Y., 1991, Rev is necessary for translation but not cytoplasmic accumulation of HIV-I vif, vpr, and env/vpu 2 RNAs, Genes Dev. 5:808–819.PubMedCrossRefGoogle Scholar
  130. 130.
    Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A., 1990, Human immunodeficiency virus vpr product is a virion-associated regulatory protein, J. Virol. 64:3097–3099.PubMedGoogle Scholar
  131. 131.
    Garrett, E. D., Tiley, L. S., and Cullen, B. R., 1991, Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products, J. Virol. 65:1653–1657.PubMedGoogle Scholar
  132. 132.
    Adachi, A., Ono, N., Sakai, H., Ogawa, K., Shibata, R., Kiyomasu, T., Masuike, H., and Ueda, S., 1991, Generation and characterization of the human immunodeficiency virus type 1 mutants, Arch. Virol. 117:45–58.CrossRefPubMedGoogle Scholar
  133. 133.
    Akari, H., Sakuragi, J,, Takebe, Y., Tomonaga, K., Kawamura, M., Fukasawa, M., Miura, T., Shinjo, T., and Hayami, M., 1992, Biological characterization of the human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells, Arch. Virol. 123:157–167.CrossRefPubMedGoogle Scholar
  134. 134.
    Cohen, E. A., Terwilliger, E. F., Jalinoos, Y., Proulx, J., Sodroski, J. G., and Haseltine, W. A., 1990, Identification of HIV-1 vpr product and function, J. Acquired Immune Defic. Syndr 3:11–18.Google Scholar
  135. 135.
    Dedera, D., Hu, W., Vander Heyden, N., and Ratner, L., 1989, Viral protein R of human immunodeficiencyvirus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells, J. Virol. 63:3205–3208.PubMedGoogle Scholar
  136. 136.
    Balliet, J. W., Kolson, D. L., Eiger, G., Kim, F. M., Mcgann K. A., Srinivasan, A., and Collman, R. G., 1994, Distinct effects in primary macrophages and lymphocytes of human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: Mutational analysis of a primary HIV-1 isolate, Virology 200:623–631.CrossRefPubMedGoogle Scholar
  137. 137.
    Zhao, L.-J., Wang, L., Mukherjee, S., and Narayan, O., 1994, Biochemical mechanism of HIV-1 Vpr function: Oligomerization mediated by the N-terminal domain, J. Biol. Chem. 269:32131–32137.PubMedGoogle Scholar
  138. 138.
    Lu, Y. L., Spearman, P., and Ratner, L., 1993, Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions, J Virol. 67:6542–6550.PubMedGoogle Scholar
  139. 139.
    Mahalingam, S., Collman, R. G., Patel, M. P., Monken, C. E., and Srinivasan, A., 1995, Functional analysis of HIV-1 Vpr: Identification of determinants essential for subcellular localization, Virology 212:331–339.CrossRefPubMedGoogle Scholar
  140. 140.
    Yao, X. J., Subramanian, R., Rougeau, N., Boisvert, F., Bergeron, D., and Cohen, E. A., 1995, Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha helical structure in Vpr nuclear localization and virion incorporation, J. Virol. 69:7032–7044.PubMedGoogle Scholar
  141. 141.
    DiMarzio, P., Choe, S., Ebright, M., Knoblough, R., and Landau, N. R., 1995, Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of the human immunodeficiency virus type 1 Vpr, J. Virol. 69:7909–7916.Google Scholar
  142. 142.
    Kondo, E., Mammano, F., Cohen, E. A., and Gottlinger, H. G., 1995, The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous virus particles, J. Virol. 69:2759–2764.PubMedGoogle Scholar
  143. 143.
    Paxton, W., Connor, R. I., and Landau, N. R., 1993, Incorporation of vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis, J. Virol. 67:7229–7237.PubMedGoogle Scholar
  144. 144.
    Wu, X., Conway, J. A., Kim, J., and Kappes, J. C., 1994, Localization of the Vpx packing signal within the C-terminus of the human immunodeficiency virus type 2 gag precursor protein, J. Virol. 68:6161–6169PubMedGoogle Scholar
  145. 145.
    Mahalingam, S., Kahn, S. A., Jabbar, M. A., Monken, C. E., Collman, R. G., and Srinivasan, A., 1995, Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation, Virology 207:297–302.CrossRefPubMedGoogle Scholar
  146. 146.
    Mahalingam, S., Kahn, S. A., Murali, R., Jabbar, M. A., Monken, C. E., Collman, R. G., and Srinivasan, A., 1995, Mutagenesis ofthe putative alpha helical domain of HIV-1 Vpr: Effect on stability and virion incorporation, Proc. Natl. Acad. Sci. USA 92:3794–3798.PubMedCrossRefGoogle Scholar
  147. 147.
    Lang, S. M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Muller, J., Muller-Hermelink, H., Fuchs, D., Wachter, H., Daniel, M., Desrosiers, R. C., and Fleckenstein, B., 1993, Importance of Vpr infection of rhesus monkeys with simian immunodeficiency virus, J. Virol. 67:902–912.PubMedGoogle Scholar
  148. 148.
    Gibbs, J. S., Lackner, A. A,, Lang, S. M., Simon, M. A., Sehgal, P. R, Daniel, M. D., and Desrosiers, R. C., 1995, Progression to AIDS in the absence of a gene for Vpr and Vpx, J. Virol. 69:2378–2383.PubMedGoogle Scholar
  149. 149.
    Cohen, E. A., Dehni, G., Sodroski, J. G., and Haseltine, W. A., 1990, Human immunodeficiency virus vpr product is a virion-associated regulatory protein, J. Virol. 64:3097–3099.PubMedGoogle Scholar
  150. 150.
    Heinzinger, N. R, Bukrinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V., Lee, M. A., Gendelman, H. E., Ratner, L., Stevensson, M., and Emerman, M., 1994, The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells, Proc. Natl. Acad. Sci. USA 91:7311–7315.PubMedCrossRefGoogle Scholar
  151. 151.
    Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B., 1993, Induction of cell differentiation by human immunodeficiency virus 1 vpr, Cell 72:541–550.CrossRefPubMedGoogle Scholar
  152. 152.
    Mahalingam, S., MacDonald, B., Ugan, K. E., Ayyavoo, V., Agadjayan, M. G., Williams, W. V., and Weiner, D. B., 1997, In vitro and in vivo tumor growth suppression by HIV-1 Vpr, DNA Cell Biol. 16:137–143.PubMedCrossRefGoogle Scholar
  153. 153.
    Rogel, M. E., Wu, L. I., and Emerman, M., 1995, The human immunodeficiencyvirus type 1 vpr gene prevents cell proliferation during chronic infection, J. Virol. 69:882–888.PubMedGoogle Scholar
  154. 154.
    He, J., Choe, S., Walker, R., DiMarzio, P., Morgan, D. O., and Landau, N. R., 1995, The human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity, J. Virol. 69:6705–6711.PubMedGoogle Scholar
  155. 155.
    Jowett, J. B. M., Planelles, V., Poon, B., Shah, N. L., Chen, M. L., and Chen, I. S. Y., 1995, The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+M phase of the cell cycle, J. Virol. 69:6304–6313.PubMedGoogle Scholar
  156. 156.
    Re, F., Braaten, D., Franke, E. R, and Luban, J., 1995, The human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B, J. Virol. 69:6859–6864.PubMedGoogle Scholar
  157. 157.
    Rogel, M. E., Wu, L. I., and Emerman, M., 1995, The human immunodeficiencyvirus type 1 vpr gene prevents cell proliferation during chronic infection, J. Virol. 69:882–888.PubMedGoogle Scholar
  158. 158.
    Mustafa, F., and Robinson, H. L., 1993, Contextdependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers, J. Virol. 67:6909–6915.PubMedGoogle Scholar
  159. 159.
    Levy, D. N., Refaeli, Y., and Weiner, D. B., 1995, The Vpr regulatory gene of human immunodeficiencyvirus, in: Transacting Functions of Human Retroviruses (I. S. Y. Chen, H. Koprowski, A. Srinivasan, and P. K. Vogt, eds.), Springer-Verlag, New York, pp. 209–236.Google Scholar
  160. 160.
    Macreadie, I. G., Castelli, L. A., Hewish, D. R., Kirkpatrick, A., Ward, A. C., and Azad, A. A., 1995, A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects, Prov. Natl. Acad. Sci. USA 92:2770–2774.CrossRefGoogle Scholar
  161. 161.
    Balliet, J. W., Kolson, D. L., Eiger, G., Kim, F. M., Mcgann, K. A., Srinivasan, A., and Collman, R. G., 1994, Distinct effects in primary macrophages and lymphocytes of human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: Mutational analysis of a primary HIV-1 isolate, Virology 200:623–631.CrossRefPubMedGoogle Scholar
  162. 162.
    Balotta, C., Lusso, P., Crowley, R., Gallo, R. C., and Franchini, G., 1993, Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages, J. Virol. 67:4409–4414.PubMedGoogle Scholar
  163. 163.
    Connor, R. I., Chen, B. K., Choe, S., and Landau, N. R., 1995, Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes, Virology 206:935–944.CrossRefPubMedGoogle Scholar
  164. 164.
    Ley, D. N., Refaeli, Y, and Weiner, D. B., 1995, Extracellular Vpr protein increase cellular permissiveness of human immunodeficiency virus replication and reactivates virus from latency, J. Virol. 69:1243–1252.Google Scholar
  165. 165.
    Refaeli, Y, Levy, D. N., and Weiner, D. B., 1995, The glucocorticoid receptor type II complex is a target of the HIV-1 Vpr gene product, Proc. Natl. Acad. Sci. USA 92:3621–3625.PubMedCrossRefGoogle Scholar
  166. 166.
    Zhao, L.-J., Mukhejee, S., and Narayan, O., 1994, Biochemical mechanism of HIV-1 Vpr function: Specific interaction with a cellular protein, J. Biol. Chem. 269:15577–15582.PubMedGoogle Scholar
  167. 167.
    BouHamdan, M., Benichou, S., Rey, F., Navarro, J. M., Agostini, I., Spire, B., Camonis, J., Sluppaug, G., Vigne, R., Benarous, R., and Sire, J., 1996, Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase (UNG) DNA repair enzyme, J. Virol. 70:697–704.PubMedGoogle Scholar
  168. 168.
    Mahalingam, S., Ayyavoo, V., Patel, M., Kao, G. D., Muschel, R. J., and Weiner, D. B., 1998, HIV-1 Vpr interacts with a 38 kDa cellular factor important for G2/M phase transition of the mammalian cell cycle, Proc. Natl. Acad. Sci. USA 95:3419–3424.CrossRefPubMedGoogle Scholar
  169. 169.
    Ayyavoo, V., Mahhoubi, A., Mahalingam, S., Ramalingam, R., Kudchodkar, S., Williams, W. V., Green, D. R., and Weiner, D. B., 1997, HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kb, Nature Med. 3:1117–1123.PubMedCrossRefGoogle Scholar
  170. 170.
    Stewart, S. A., Poon, B., Jowett, J. B., and Chen, I. S., 1997, Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest, J. Virol. 71:5579–5592.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Sagar Kudchodkar
    • 1
  • T. Nagashunmugam
    • 1
  • Velpandi Ayyavoo
    • 2
  1. 1.Stellar-Chance Laboratories, Department of Pathology and Laboratory MedicineUniversity of PennsylvaniaPhiladelphia
  2. 2.Department of Infectious Diseases and MicrobiologyUniversity of PittsburghPittsburgh

Personalised recommendations